Mettler-toledo International Inc. (MTD)

$1217.97

+21.15

(+1.77%)▲

Market is closed - opens 8 PM, 25 Nov 2024

Performance

  • $1,194.37
    $1,225.24
    $1,217.97
    downward going graph

    1.94%

    Downside

    Day's Volatility :2.52%

    Upside

    0.59%

    downward going graph
  • $1,059.08
    $1,546.93
    $1,217.97
    downward going graph

    13.05%

    Downside

    52 Weeks Volatility :31.54%

    Upside

    21.27%

    downward going graph

Returns

PeriodMettler-toledo International Inc.Sector (Health Care)S&P500
3 Months
-15.18%
-7.3%
5.9%
6 Months
-17.67%
-0.5%
13.3%
1 Year
11.38%
10.5%
31.0%
3 Years
-20.09%
8.8%
27.3%

Highlights

Market Capitalization
25.3B
Book Value
-$7.31
Earnings Per Share (EPS)
37.1
PE Ratio
32.26
PEG Ratio
2.52
Wall Street Target Price
1327.929
Profit Margin
21.15%
Operating Margin TTM
29.36%
Return On Assets TTM
20.14%
Return On Equity TTM
29.51%
Revenue TTM
3.8B
Revenue Per Share TTM
176.1
Quarterly Revenue Growth YOY
1.3%
Gross Profit TTM
2.3B
EBITDA
1.1B
Diluted Eps TTM
37.1
Quarterly Earnings Growth YOY
0.08
EPS Estimate Current Year
40.58
EPS Estimate Next Year
42.34
EPS Estimate Current Quarter
10.01
EPS Estimate Next Quarter
11.86

Analyst Recommendation

Hold
    5%Buy
    63%Hold
    31%Sell
Based on 19 Wall street analysts offering stock ratings for Mettler-toledo International Inc.(by analysts ranked 0 to 5 stars)
Based on 19 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
1
1
1
Hold
12
12
11
Sell
6
6
7

Analyst Forecast

What analysts predicted

Upside of 9.03%

Current $1,217.97
Target $1,327.93

Company Financials

FY18Y/Y Change
Revenue
2.9B
↑ 7.73%
Net Income
512.6M
↑ 36.34%
Net Profit Margin
17.46%
↑ 3.66%
FY19Y/Y Change
Revenue
3.0B
↑ 2.49%
Net Income
561.1M
↑ 9.46%
Net Profit Margin
18.65%
↑ 1.19%
FY20Y/Y Change
Revenue
3.1B
↑ 2.54%
Net Income
602.7M
↑ 7.42%
Net Profit Margin
19.54%
↑ 0.89%
FY21Y/Y Change
Revenue
3.7B
↑ 20.51%
Net Income
769.0M
↑ 27.58%
Net Profit Margin
20.68%
↑ 1.14%
FY22Y/Y Change
Revenue
3.9B
↑ 5.43%
Net Income
872.5M
↑ 13.46%
Net Profit Margin
22.26%
↑ 1.58%
FY23Y/Y Change
Revenue
3.8B
↓ 3.35%
Net Income
788.8M
↓ 9.6%
Net Profit Margin
20.82%
↓ 1.44%
Q2 FY23Q/Q Change
Revenue
982.1M
↑ 5.75%
Net Income
213.9M
↑ 13.53%
Net Profit Margin
21.78%
↑ 1.49%
Q3 FY23Q/Q Change
Revenue
942.5M
↓ 4.04%
Net Income
201.6M
↓ 5.75%
Net Profit Margin
21.39%
↓ 0.39%
Q4 FY23Q/Q Change
Revenue
935.0M
↓ 0.79%
Net Income
184.8M
↓ 8.35%
Net Profit Margin
19.76%
↓ 1.63%
Q1 FY24Q/Q Change
Revenue
925.9M
↓ 0.97%
Net Income
177.5M
↓ 3.94%
Net Profit Margin
19.17%
↓ 0.59%
Q2 FY24Q/Q Change
Revenue
946.8M
↑ 2.25%
Net Income
221.8M
↑ 24.96%
Net Profit Margin
23.43%
↑ 4.26%
Q3 FY24Q/Q Change
Revenue
954.5M
↑ 0.82%
Net Income
211.5M
↓ 4.64%
Net Profit Margin
22.16%
↓ 1.27%
FY18Y/Y Change
Total Assets
2.6B
↑ 2.71%
Total Liabilities
2.0B
↑ 1.31%
FY19Y/Y Change
Total Assets
2.8B
↑ 6.51%
Total Liabilities
2.4B
↑ 16.75%
FY20Y/Y Change
Total Assets
2.8B
↑ 0.9%
Total Liabilities
2.5B
↑ 6.9%
FY21Y/Y Change
Total Assets
3.3B
↑ 18.2%
Total Liabilities
3.2B
↑ 24.63%
FY22Y/Y Change
Total Assets
3.5B
↑ 4.98%
Total Liabilities
3.5B
↑ 9.9%
FY23Y/Y Change
Total Assets
3.4B
↓ 3.92%
Total Liabilities
3.5B
↑ 1.09%
Q2 FY23Q/Q Change
Total Assets
3.4B
↓ 1.16%
Total Liabilities
3.5B
↑ 0.75%
Q3 FY23Q/Q Change
Total Assets
3.3B
↓ 2.42%
Total Liabilities
3.4B
↓ 1.89%
Q4 FY23Q/Q Change
Total Assets
3.4B
↑ 2.03%
Total Liabilities
3.5B
↑ 3.27%
Q1 FY24Q/Q Change
Total Assets
3.3B
↓ 2.16%
Total Liabilities
3.4B
↓ 1.82%
Q2 FY24Q/Q Change
Total Assets
3.2B
↓ 1.03%
Total Liabilities
3.4B
↓ 1.16%
Q3 FY24Q/Q Change
Total Assets
3.3B
↑ 2.17%
Total Liabilities
3.5B
↑ 2.12%
FY18Y/Y Change
Operating Cash Flow
565.0M
↑ 9.43%
Investing Cash Flow
-138.9M
↓ 36.07%
Financing Cash Flow
-388.0M
↑ 21.44%
FY19Y/Y Change
Operating Cash Flow
603.5M
↑ 6.8%
Investing Cash Flow
-99.1M
↓ 28.69%
Financing Cash Flow
-477.4M
↑ 23.03%
FY20Y/Y Change
Operating Cash Flow
724.7M
↑ 20.09%
Investing Cash Flow
-100.4M
↑ 1.29%
Financing Cash Flow
-743.9M
↑ 55.84%
FY21Y/Y Change
Operating Cash Flow
908.8M
↑ 25.41%
Investing Cash Flow
-314.1M
↑ 212.98%
Financing Cash Flow
-590.5M
↓ 20.62%
FY22Y/Y Change
Operating Cash Flow
859.1M
↓ 5.47%
Investing Cash Flow
-139.4M
↓ 55.62%
Financing Cash Flow
-716.0M
↑ 21.25%
Q2 FY23Q/Q Change
Operating Cash Flow
266.8M
↑ 74.09%
Investing Cash Flow
-42.9M
↑ 91.69%
Financing Cash Flow
-227.4M
↑ 65.24%
Q3 FY23Q/Q Change
Operating Cash Flow
264.3M
↓ 0.94%
Investing Cash Flow
-96.2M
↑ 124.16%
Financing Cash Flow
-245.6M
↑ 7.97%

Technicals Summary

Sell

Neutral

Buy

Mettler-toledo International Inc. is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Mettler-toledo International Inc.
Mettler-toledo International Inc.
-7.75%
-17.67%
11.38%
-20.09%
69.88%
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
-8.88%
-19.16%
-12.74%
-32.7%
65.66%
Agilent Technologies Inc.
Agilent Technologies Inc.
0.61%
-11.1%
5.7%
-13.53%
66.76%
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
-10.97%
-12.27%
4.58%
-18.89%
65.25%
Danaher Corp.
Danaher Corp.
-7.87%
-9.78%
6.52%
-24.78%
62.72%
Iqvia Holdings Inc.
Iqvia Holdings Inc.
-11.6%
-11.13%
-4.81%
-23.92%
37.77%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Mettler-toledo International Inc.
Mettler-toledo International Inc.
32.26
32.26
2.52
40.58
0.3
0.2
NA
-7.31
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
40.32
40.32
4.41
10.73
0.59
0.23
NA
19.72
Agilent Technologies Inc.
Agilent Technologies Inc.
27.46
27.46
2.77
5.24
0.25
0.08
0.01
20.53
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
32.36
32.36
1.95
21.69
0.13
0.05
0.0
128.08
Danaher Corp.
Danaher Corp.
44.43
44.43
2.74
7.5
0.08
0.04
0.0
71.03
Iqvia Holdings Inc.
Iqvia Holdings Inc.
26.52
26.52
1.03
11.14
0.22
0.05
NA
38.37
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Mettler-toledo International Inc.
Mettler-toledo International Inc.
Hold
$25.3B
69.88%
32.26
21.15%
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
Buy
$34.3B
65.66%
40.32
22.53%
Agilent Technologies Inc.
Agilent Technologies Inc.
Buy
$37.9B
66.76%
27.46
21.75%
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
Buy
$197.4B
65.25%
32.36
14.48%
Danaher Corp.
Danaher Corp.
Buy
$169.8B
62.72%
44.43
16.39%
Iqvia Holdings Inc.
Iqvia Holdings Inc.
Buy
$36.6B
37.77%
26.52
9.17%

Insights on Mettler-toledo International Inc.

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 925.94M → 954.53M (in $), with an average increase of 1.5% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 221.81M → 211.51M (in $), with an average decrease of 4.6% per quarter

  • Vs A

    In the last 3 years, Mettler-toledo International Inc. has experienced a drawdown of -20.1%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 6.6%

Institutional Holdings

  • Vanguard Group Inc

    11.94%

  • BlackRock Inc

    8.81%

  • Capital Research & Mgmt Co - Division 3

    4.54%

  • State Street Corp

    4.48%

  • Morgan Stanley - Brokerage Accounts

    2.94%

  • Fundsmith LLP

    2.80%

Company Information

mettler toledo is a global manufacturer and marketer of precision instruments for use in laboratory, industrial and food retailing applications. the company has strong worldwide leadership positions. a significant majority of our instrument sales are in segments in which we are the global leader. in addition to a broad product offering, we have one of the largest global sales and service organizations among precision instrument companies. we focus on the high value-added segments of our markets by providing innovative instruments that often integrate various technologies including application-specific solutions for customers. we design our instruments not only to gather valuable data but also to facilitate the processing and transfer of this data into customers' management information systems.

Organization
Mettler-toledo International Inc.
Employees
16000
CEO
Mr. Patrick K. Kaltenbach
Industry
Health Technology

FAQs